The Use of Social Media Listening for Targeted Recruitment of Twitter Users in LA County in Cancer Trials Compared to Historic Recruitment Data: A Mixed-Methods Study
Description
Brief Summary
This pilot clinical trial studies how well social media listening works in improving clinical
trial recruitment in patients with cancer. Social media listening and recruitment on Twitter
may enhance enrollment for cancer-related clinical trials.
Detailed Description
I. Examine the feasibility (acceptance among University of Southern California [USC] Norris
study team members and Twitter users in Los Angeles [LA] county) of targeted social media
listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials.
II. Gain preliminary data on the impact (i.e., numbers recruited versus projected accrual
compared to historic recruitment) of targeted social media listening (SML) as a tool for
enhancing recruitment to cancer trials among Twitter users in LA county.
III. Estimate the effect size of the number of people enrolled associated with the use of
targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to
cancer trials.
OUTLINE:
Patients who mention specific cancer disease keywords and/or hashtags are identified and
receive a message via Twitter. Patients are then contacted for recruitment into a clinical
trial.
Phase
N/AInclusion and Exclusion Criteria
- TRIAL INCLUSION:
- Focus on one of the following disease categories: non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, kidney cancer, lymphoma
- Be a phase 1 trial in expansion, phase 2, or 3
- Be interventional trials
- Recruit in English
- Be Institutional Review Board (IRB)-approved and open to accrual at USC Norris
- Recruit for at least 9 months at the point of enrollment
- Set monthly accrual target >= 1/ and annual accrual target >= 12
- PATIENT INCLUSION:
- Will include all prospective trial participants in this study that come from Twitter in response of our SM recruitment interventions, provided they meet the specific trial's eligibility criteria
- TRIAL EXCLUSION:
- Phase 1 trials in dose escalation
- PATIENT EXCLUSION:
- Persons who do not meet the eligibility criteria of any of the trials open to accrual will be excluded from participation, and persons who may be eligible (e.g., disease/histology, stage, prior treatment) but do not meet additional trial-specific requirements such as insurance or allergy to drug)
Sites
Please contact the trial administrator to learn more about where you can participate in this trial. Please use the contact form on the right side.
Powered by
SC CTSI